Get the Stockscreener App
44.96
2.02%
0.89
After Hours:
45.50
0.54
+1.20%
Harrow Inc stock is traded at $44.96, with a volume of 600.46K.
It is up +2.02% in the last 24 hours and up +11.12% over the past month.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
See More
Previous Close:
$44.07
Open:
$43.66
24h Volume:
600.46K
Relative Volume:
1.13
Market Cap:
$1.58B
Revenue:
$130.19M
Net Income/Loss:
$-24.41M
P/E Ratio:
-80.29
EPS:
-0.56
Net Cash Flow:
$-148.71M
1W Performance:
+1.17%
1M Performance:
+11.12%
6M Performance:
+239.83%
1Y Performance:
+212.87%
1-Day Range:
$43.66
$46.82
1-Week Range:
$43.33
$46.82
52-Week Range:
$7.60
$47.55
Harrow Inc Stock (HROW) Company Profile
Name
Harrow Inc
Sector
Phone
615.733.4731
Address
102 WOODMONT BLVD, NASHVILLE, CA
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-22 | Resumed | B. Riley Securities | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Sep-24-21 | Initiated | Aegis Capital | Buy |
| Jul-02-21 | Initiated | Ladenburg Thalmann | Buy |
Harrow Inc Stock (HROW) Latest News
Harrow Inc (HROW) Stock Price Up 3.44% on Sep 30 - GuruFocus.com
Harrow Announces Corporate Headquarters Expansion in Nashville - Vision Monday
Renaissance Technologies LLC Sells 171,150 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Short Interest in Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Expands By 225.0% - Defense World
Harrow Inc. invests millions to grow Nashville workforce - The Business Journals
Harrow to create 147 jobs with headquarters expansion - Nashville Post
Harrow Inc. expands Nashville headquarters, adding 150 jobs - Investing.com
Governor Lee, Commissioner McWhorter Announce Harrow, Inc. Expansion in Davidson County - Tennessee Department of Economic & Community Development
Harrow Announces Nashville Expansion - StockTitan
Harrow Inc (HROW) Becoming More Attractive for Investors - Knox Daily
Apis Capital Advisors LLC Invests $1.66 Million in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Pinner company honoured with ‘King’s Award for Enterprise’ - Harrow Online
Harrow (NASDAQ:HROW) Hits New 12-Month High at $47.55 - Defense World
Harrow Inc (HROW) Stock Price Down 2.73% on Sep 20 - GuruFocus.com
Harrow (NASDAQ:HROW) Reaches New 1-Year High at $47.55 - MarketBeat
HROW (Harrow) Financial Strength : 5 (As of Jun. 2024) - GuruFocus.com
Bank of New York Mellon Corp Buys 12,580 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Understanding the Risks of Investing in Harrow Inc (HROW) - Knox Daily
Harrow Market Booming Worldwide With Leading Key Players -Baldan, Breviglieri, Rome Plow Company, AMCO Manufacturing, Inc., RemlingerMfg, Ri – Third Eye News - Third Eye News
Harrow (NASDAQ:HROW) Sets New 52-Week High at $44.90 - MarketBeat
Harrow Inc (HROW) rating initates by Craig Hallum - Knox Daily
Los Angeles Capital Management LLC Buys New Holdings in Harrow, Inc. (NASDAQ:HROW) - Defense World
Los Angeles Capital Management LLC Invests $1.70 Million in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Trailed Disc Harrow Market Growth Opportunities and Trends Analysis - Daily News Mirror
Mounted Disc Harrow Market Size, Market Resilience and Forecasted Scenarios (2024-2034) - Daily News Mirror
Harrow (NASDAQ:HROW) Stock Price Up 5.3% - MarketBeat
Harrow: 3 Business Models, And CEO Stardom (NASDAQ:HROW) - Seeking Alpha
Harrow Health Unveils Performance Strategy to Investors - TipRanks
nVerses Capital LLC Makes New $33,000 Investment in Harrow, Inc. (NASDAQ:HROW) - Defense World
2024's 10 Best-Performing Stocks - MSN
Craig Hallum’s latest rating for HROW stock - Knox Daily
Harrow to Present at Three Investor Conferences in September in New York - Business Wire
Harrow (NASDAQ:HROW) Given “Buy” Rating at B. Riley - Defense World
Harrow (NASDAQ:HROW) Given Buy Rating at B. Riley - MarketBeat
A company insider recently bought 20,000 shares of Harrow Inc [HROW]. Should You Buy? - Knox Daily
Navigating 5 Analyst Ratings For Harrow - Benzinga
Harrow Inc (HROW) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Ratios Uncovered: Breaking Down Harrow Inc (HROW)’s Trailing Twelve Months Metrics - The Dwinnex
A stock that deserves closer examination: Harrow Inc (HROW) - US Post News
Chart of the Day: HarrowEye Care Pharma - Nasdaq
Chart of the Day: HarrowEye Care Pharma - Inkl
Chart Of The Day: HarrowEye Care Pharma - Barchart
Taking a Closer Look At Harrow Inc (HROW) Following Its Recent Trade - Knox Daily
Nothing is Better Than Harrow Inc (HROW) stock at the moment - SETE News
Harrow (NASDAQ:HROW) Reaches New 12-Month High at $43.24 - Defense World
Harrow (NASDAQ:HROW) Hits New 1-Year High at $43.24 - MarketBeat
Harrow (NASDAQ:HROW) Trading Up 3% - Defense World
Harrow extends gains to hit new 52-week high - MSN
HROW Shares Experience Surge in Value - Knox Daily
Harrow Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle
Harrow (NASDAQ:HROW) Trading Up 3% - MarketBeat
Harrow Inc Stock (HROW) Financials Data
Revenue
Net Income
Cash Flow
EPS
Harrow Inc Stock (HROW) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Apr 25 '24 |
Buy |
9.97 |
20,000 |
199,400 |
3,815,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 23 '24 |
Buy |
10.29 |
11,715 |
120,547 |
3,786,715 |
| Opaleye Management Inc. | 10% Owner |
Apr 24 '24 |
Buy |
10.15 |
8,285 |
84,093 |
3,795,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 19 '24 |
Buy |
10.56 |
29,400 |
310,390 |
3,775,000 |
| Opaleye Management Inc. | 10% Owner |
Mar 28 '24 |
Buy |
12.82 |
50,000 |
641,000 |
3,745,600 |
| BAUM MARK L | CHIEF EXECUTIVE OFFICER |
Mar 22 '24 |
Buy |
11.59 |
9,000 |
104,310 |
2,137,525 |
| Opaleye Management Inc. | 10% Owner |
Mar 20 '24 |
Buy |
9.65 |
50,600 |
488,290 |
3,695,600 |
| SAHAREK JOHN P. | CEO of ImprimisRx |
Mar 01 '24 |
Option Exercise |
8.75 |
5,000 |
43,750 |
254,803 |
| SAHAREK JOHN P. | CEO of ImprimisRx |
Feb 20 '24 |
Option Exercise |
10.67 |
30,000 |
320,100 |
262,419 |
| BOLL ANDREW R. | CHIEF FINANCIAL OFFICER |
Feb 20 '24 |
Option Exercise |
10.67 |
45,000 |
480,150 |
586,569 |
2.23%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):